NEUPHARMA, INC.
Patent Owner
Stats
- 19 US PATENTS IN FORCE
- 3 US APPLICATIONS PENDING
- Mar 15, 2018 most recent publication
Details
- 19 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 389 Total Citation Count
- Aug 22, 2011 Earliest Filing
- 2 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0196,881 SUBSTITUTED QUINAZOLINES FOR INHIBITING KINASE ACTIVITYNov 22, 16Jul 13, 17[A61K, C12Q, G01N]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9849139 Substituted quinazolines for inhibiting kinase activityNov 22, 16Dec 26, 17[A61K, C12Q, G01N]
9676813 Certain steroids and methods for using the same in the treatment of cancerApr 29, 13Jun 13, 17[A61K, C07J]
9572808 Benzenesulfonamide derivatives of quinoxaline, pharmaceutical compositions thereof, and their use in methods for treating cancerDec 17, 15Feb 21, 17[A61K, C12Q, C07D, G01N, A61P]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0050,936 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODSAbandonedAug 22, 14Feb 23, 17[A61K, C07D, C07C]
2017/0050,938 SUBSTITUTED QUINOXALINES AS B-RAF KINASE INHIBITORSAbandonedAug 02, 16Feb 23, 17[A61K, C07D]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.